Vicarious Surgical Q1 2025: GAAP net loss $15.4M; FY cash burn guided ~$50M

Vicarious Surgical Inc.

GAAP net loss $15.4M ($2.60/shr) vs $17.0M ($2.90) Q1 2024; adjusted net loss $15.3M ($2.58/shr).
Operating expenses $15.7M, down 2% YoY; R&D $9.4M, G&A $5.3M, S&M $1.0M.
Cash and investments $37.4M at March 31, 2025; Q1 cash burn $11.7M.
Full-year 2025 cash burn guidance approximately $50 million.
CEO says company is 'just a few quarters away' from first clinical patients.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.